## Distinguishing Desflurane from Nitrous Oxide ### Fundamental Difference in Anesthetic Potency **Key Point:** The **MAC value** is the cardinal discriminator. Desflurane (MAC 6%) is a potent volatile anesthetic capable of producing surgical anesthesia as a sole agent. Nitrous oxide (MAC 104%) is **supramaximal** — it cannot achieve surgical anesthesia at clinically tolerable concentrations (max ~70% to maintain oxygenation), making it a **weak analgesic adjunct only**. ### Comparative Properties | Property | Desflurane | Nitrous Oxide | | --- | --- | --- | | **MAC** | 6% | 104% (supramaximal) | | **Anesthetic potency** | Potent; sole agent | Weak; adjunct only | | **Blood–gas coefficient** | 0.42 | 0.47 | | **Emergence time** | Rapid (low solubility) | Rapid (low solubility) | | **Airway irritation** | Marked (unsuitable for induction) | Minimal | | **Hepatic metabolism** | ~0.02% | 0% (eliminated unchanged) | | **Analgesic potency** | Minimal | Moderate (analgesic properties) | | **Clinical role** | Primary volatile agent | Adjunct for analgesia & anxiolysis | ### High-Yield Concept **High-Yield:** The **MAC > 100%** concept for nitrous oxide is pathognomonic. It defines why N₂O can never be a primary anesthetic — you cannot deliver enough at safe oxygen concentrations. This is the single most important distinction in clinical anesthesia. ### Clinical Pearl **Clinical Pearl:** Modern anesthesia uses desflurane (or sevoflurane) as the primary volatile agent, with nitrous oxide reserved for **adjunctive analgesia** (reduces opioid requirement by ~25–50%) and anxiolysis. The combination is synergistic but N₂O is never the primary anesthetic. [cite:Miller's Anesthesia 8e Ch 26]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.